Adenosine A2AReceptor Antagonists: New 8-Substituted 9-Ethyladenines as Tools for in vivo Rat Models of Parkinson's Disease-Reference-Cited by-同舟云学术

Adenosine A2AReceptor Antagonists: New 8-Substituted 9-Ethyladenines as Tools for in vivo Rat Models of Parkinson's Disease

Published:2009-06-08 Issue:6 Volume:4 Page:1010-1019
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Volpini Rosaria,Dal Ben Diego,Lambertucci Catia,Marucci Gabriella,Mishra Ram Chandra,Ramadori Anna Teresa,Klotz Karl-Norbert,Trincavelli Maria Letizia,Martini Claudia,Cristalli Gloria

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cmdc.200800434/fullpdf

Reference42 articles.

1. Adenosine receptors as therapeutic targets

2. Medicinal Chemistry of Adenosine A1 Receptor Ligands

3. Molecular characterization of recombinant human adenosine receptors

4. Adenosine, an endogenous distress signal, modulates tissue damage and repair

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of Parkinson's Disease: Current Treatments and Recent Therapeutic Developments;Current Drug Discovery Technologies;2023-09

2. Bioactive Furanyl- or Thienyl-Substituted Nucleobases, Nucleosides and Their Analogues;Mini-Reviews in Medicinal Chemistry;2023-03

3. Adenosine A2A Receptor Antagonists: Chemistry, SARs, and Therapeutic Potential;Topics in Medicinal Chemistry;2023

4. Screening and Characterizing of GPCR –Ligand Interactions with Mass Spectrometry‐Based Technologies;GPCRs as Therapeutic Targets;2022-09-16

5. A_2A Adenosine Receptor Antagonists and their Potential in Neurological Disorders;Current Medicinal Chemistry;2022-08